Jove
Visualize
联系我们

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative evaluation of automated MRI-based brain volumetry software for estimating cognitive domains in early Alzheimer's disease.

BMC medical imaging·2026
Same author

Prediction of FLAIR MRI from <sup>18</sup>F-FDG PET/CT for the Evaluation of White Matter Hyperintensity Using Generative Adversarial Network.

Journal of imaging informatics in medicine·2026
Same author

Association of White Matter Hyperintensities, Regional Brain Glucose Metabolism, and Cognitive Impairment in Aβ-Negative Patients.

Neurology·2026
Same author

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.

Nature medicine·2026
Same author

Effect of tau burden and Lewy pathology on neuropsychiatric symptoms in Aβ-positive individuals.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Putaminal hypermetabolism identifies Lewy body co-pathology in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Young-Gun Lee1

  • 1Ilsan Paik Hospital, Inje University College of Meidicine, Goyang, Gyeonggi, Korea, Republic of (South).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

阿尔茨海默病 (AD) 的临床和生物分期之间的差异预测了预后. 临床阶段较差的患者表现出更快的衰退和更高的风险,而更好的临床阶段表明风险较低.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 神经学 神经学
  • 生物标志物 生物标志物

背景情况:

  • 阿尔茨海默病 (AD) 呈现出显著的异质性.
  • 综合临床和生物分期可能会阐明导致AD变化的因素.

研究的目的:

  • 研究将阿尔茨海默病的临床和生物分期整合到阿尔茨海默病中的预后影响.
  • 根据认知和陶沉积阶段之间的差异对参与者进行分类.

主要方法:

  • 利用了阿尔茨海默病神经成像计划的193名参与者的数据.
  • 使用W-分数测量了临床 (认知) 和生物 (tau沉积) 阶段之间的差异.
  • 将参与者分为一致 (W0),更差的临床 (W-) 和更好的临床 (W+) 阶段组.

主要成果:

  • W-组表现出更快的认知衰退和更高的进展风险 (HR=2.40).
  • 在W+组中,进展风险较低 (HR=0.43).
  • 同病理负担与W分数相关,W组显示较高的脑脊髓α-synuclein阳性和较低的大脑代谢.

结论:

  • 对阿尔茨海默病的综合分期方案具有显著的临床效用.
  • 这种方法有助于预测AD的预后,并了解潜在的共同病理.